As filed with the Securities and Exchange Commission on July 19, 2005
Registration No. 333-107318
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
POST-EFFECTIVE AMENDMENT NO. 1
TO
FORM S-3
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
HOLLIS-EDEN PHARMACEUTICALS, INC.
(Exact name of registrant as specified in its charter)
| Delaware | 13-3697002 | |
| (State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
4435 EASTGATE MALL, SUITE 400
SAN DIEGO, CALIFORNIA 92121
(858) 587-9333
(Address, including zip code, and telephone number, including area code, of Registrant’s principal executive offices)
RICHARD B. HOLLIS
CHAIRMAN OF THE BOARD AND CHIEF EXECUTIVE OFFICER
HOLLIS-EDEN PHARMACEUTICALS, INC.
4435 EASTGATE MALL, SUITE 400
SAN DIEGO, CALIFORNIA 92121
(858) 587-9333
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Copies to:
ERIC J. LOUMEAU, ESQ.
HOLLIS-EDEN PHARMACEUTICALS, INC.
4435 EASTGATE MALL, SUITE 400
SAN DIEGO, CALIFORNIA 92121
(858) 587-9333
DEREGISTRATION OF SECURITIES
This Post-Effective Amendment No. 1 to the Registration Statement on Form S-3 originally filed by Hollis-Eden Pharmaceuticals, Inc. (the “Registrant”) with the Commission on July 24, 2003 (Registration No. 333-107318) (the “Registration Statement”), is being filed to deregister certain shares of the Registrant’s common stock (the “Shares”), warrants to purchase shares of the Registrant’s common stock (the “Warrants”), and the shares of the Registrant’s common stock issuable upon the exercise of the Warrants (the “Warrant Shares”). The Registrant previously registered, pursuant to the Registration Statement, Shares, Warrants and Warrant Shares in an aggregate amount of 5,000,000 shares of the Registrant’s common stock (collectively, the “Securities”). As of the date hereof, the Registrant had completed two public offerings in which it issued an aggregate of 4,100,000 of the Securities under the Registration Statement. The Registrant does not intend to sell any additional Securities under the Registration Statement. Accordingly, pursuant to an undertaking made in Item 17 of the Registration Statement, the Registrant hereby deregisters the 900,000 Securities that remain unsold as of the date hereof.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this Post-Effective Amendment No. 1 to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of San Diego, State of California on July 19, 2005.
| HOLLIS-EDEN PHARMACEUTICALS, INC. | ||
| By: | /s/ Richard B. Hollis | |
| Richard B. Hollis | ||
| Chairman of the Board and Chief Executive Officer | ||
Pursuant to the requirements of the Securities Act, this Post-Effective Amendment No. 1 to the Registration Statement has been signed below by the following persons in the capacities and on the dates indicated.
| Signatures |
Title |
Date | ||
| /s/ Richard B. Hollis |
Chairman of the Board, Chief Executive Officer and Director (Principal Executive Officer) | July 19, 2005 | ||
| Richard B. Hollis |
||||
| /s/ Daniel D. Burgess |
Chief Operating Officer/Chief Financial Officer (Principal Financial Officer) | July 19, 2005 | ||
| Daniel D. Burgess |
||||
| /s/ Robert W. Weber |
Vice-President-Controller/Chief Accounting Officer (Principal Accounting Officer) | July 19, 2005 | ||
| Robert W. Weber |
||||
| /s/ * |
Director | July 19, 2005 | ||
| J. Paul Bagley III |
||||
| /s/ * |
Director | July 19, 2005 | ||
| Jerome M. Hauer |
||||
| /s/ * |
Director | July 19, 2005 | ||
| Brendan R. McDonnell |
||||
| /s/ * |
Director | July 19, 2005 | ||
| Thomas Charles Merigan, Jr |
||||
| /s/ * |
Director | July 19, 2005 | ||
| Marc R. Sarni |
||||
| /s/ * |
Director | July 19, 2005 | ||
| Salvatore J. Zizza |
||||
| /s/ Richard B. Hollis |
||||
| * By: Richard B. Hollis, as attorney-in-fact |
||||